Lv1
8 积分 2026-10-20 加入
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial
17小时前
已完结
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
18小时前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
18小时前
已完结
Anti-ANGPTL3 Antibody SHR-1918 for Homozygous Familial Hypercholesterolemia
18小时前
已完结
皖公网安备34019202002308
